{"id":44698,"date":"2019-05-24T14:32:16","date_gmt":"2019-05-24T13:32:16","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=44698"},"modified":"2019-05-31T11:45:03","modified_gmt":"2019-05-31T10:45:03","slug":"jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/","title":{"rendered":"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary"},"content":{"rendered":"

\"jeffrey_aronson\"<\/a>In my recent articles on how outcomes are assessed in clinical studies I have covered the minimal clinically important difference (<\/span>MCID<\/span><\/a>), a measure of how large a change in the patient\u2019s condition needs to be to justify using an intervention, assuming a good benefit to harm balance and cost-effectiveness; the minimal important difference (<\/span>MID<\/span><\/a>), a similar measure, omission of the word \u201cclinically\u201d being intended to focus attention on the patient rather than the clinician; the size of the difference, which should be, but is not always, <\/span>important<\/span><\/a> to the patient, and may be important to others, such as family or carers, or even the clinician; and the patient acceptable symptom state (<\/span>PASS<\/span><\/a>), a rarely used term, intended to focus on \u201cthe highest level of symptom beyond which patients consider themselves well\u201d.<\/span><\/p>\n

I concluded that it would be helpful to introduce two new concepts to clarify the ideas that the various terms imply: minimum desirable benefits and maximum acceptable harms. These terms imply that what is acceptable to the patient (or family or carers) in terms of beneficial outcomes may not be what the patient actually wants, and that whatever the patient wants in the way of benefit must be tempered by the realization that harms can occur and that what matters is not either the desire to achieve benefit nor the hope of avoiding harms, but a combination of the two, commonly expressed as the <\/span>benefit to harm balance<\/span><\/a>.<\/span><\/p>\n

Having then <\/span>considered<\/span><\/a> reported outcomes I thought it worth going on to consider primary and secondary outcomes or endpoints. And here a cautionary tale is relevant. Having completed <\/span>ISIS-2<\/span><\/a>, a randomized trial of intravenous streptokinase, oral aspirin, both, or neither in 17\u00a0187 patients with suspected acute myocardial infarction, Richard Peto and his colleagues submitted the manuscript to the Lancet<\/em>. It was accepted, but on condition that subgroup analyses be included. Peto demurred, but the journal insisted, so he agreed, but slipped in an analysis of subgroups according to their astrological birth sign. Peto later published the complete data in the <\/span>British Journal of Cancer<\/a> <\/em>(Figure 1).<\/span><\/p>\n

\"\"
With permission from Springer Nature<\/figcaption><\/figure>\n

Figure 1.<\/b> A subgroup analysis of the results of ISIS-2 by astrological birth sign (from Peto, <\/span>2011<\/span><\/a>); the authors of the ISIS-2 study had described these results in their paper as follows: \u201cfor patients born under Gemini or Libra there was a slightly adverse effect of aspirin on mortality while for patients born under all other astrological signs there was a strikingly beneficial effect\u201d.\u00a0<\/span><\/p>\n

The Lancet<\/em>\u2019s insistence in this case was surprising, The dangers of subgroup analyses and ways of dealing with them were already well known. For example, John Tukey published his range test for multiple comparisons in analysis of variance in <\/span>1949<\/span><\/a> and Olive Jean Dunn published what became known as the Bonferroni correction technique in <\/span>1961<\/span><\/a>.<\/span><\/p>\n

One consequence of this understanding was that it became de rigueur to identify in advance the outcomes in clinical trials, details of which were to be collected and analysed, as described in the first CONSORT statement in <\/span>1996<\/span><\/a>. In a parallel development, the division of outcomes into primary and secondary, to be prespecified and analysed and interpreted separately, was introduced into clinical trials by at least the 1980s (Figure 2). The earliest example I have found dates from 1985, although it was already a concept in <\/span>management<\/span><\/a>. <\/span>Furthermore, primary and secondary outcomes were undoubtedly specified before then in trials that were published only later. For example, the prospective study known as the <\/span>UKPDS<\/span><\/a>, which reported primary and secondary outcomes starting in the 1990s, randomized its first patients in the late 1970s.<\/span><\/p>\n

\"\"<\/p>\n

Figure 2.<\/b> Numbers of publications since 1985 containing the terms \u201cprimary outcomes\/endpoints\u201d and \u201csecondary outcomes\/endpoints\u201d (source textwords in PubMed)<\/span><\/p>\n

The primary outcome is the one that the trialists decide is a priority. The sample size is then calculated assuming a predicted desirable, or simply attainable, effect size and the sizes of the type 1 and type 2 errors. If the trial is large enough, it may be possible to make judgements about the secondary endpoints, if positive effects occur. Even if the results are negative, some conclusions may be possible, depending on the confidence intervals. An arbitrarily large study would be likely to be sufficiently powered to allow conclusions about at least some of the secondary outcomes, although it might be impossible to make accurate calculations in advance, if the anticipated effect sizes are not known or if some endpoints are rare (e.g. adverse effects or adverse reactions).<\/span><\/p>\n

One way of approaching this problem would be to choose a <\/span>core set of outcomes<\/span><\/a> for specific problems, which could be duplicated across all relevant studies and about which enough is known to allow calculations to be made in advance. This and other aspects of outcomes, such as composite outcomes, biomarkers, and inappropriate or misleading reporting of outcomes, require separate consideration.<\/span><\/p>\n

Acknowledgements:<\/strong> Thanks for helpful comments from my colleagues in the Centre for Evidence Based Medicine in Oxford, Kamal Mahtani, Annette Pl\u00fcddemann, and Richard Stevens.<\/span><\/p>\n

Jeffrey Aronson<\/strong>\u00a0is a clinical pharmacologist, working in the Centre for Evidence Based Medicine in Oxford’s Nuffield Department of Primary Care Health Sciences. He is also president emeritus of the British Pharmacological Society.<\/em><\/p>\n

Competing interests:<\/strong>\u00a0None declared.<\/p>\n","protected":false},"excerpt":{"rendered":"

In my recent articles on how outcomes are assessed in clinical studies I have covered the minimal clinically important difference (MCID), a measure of how large a change in the […]<\/p>\n

More…<\/a><\/p>\n","protected":false},"author":1,"featured_media":38359,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5762],"tags":[],"class_list":["post-44698","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jeff-aronsons-words"],"yoast_head":"\nJeffrey Aronson: When I use a word . . . Outcomes, primary and secondary - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary - The BMJ\" \/>\n<meta property=\"og:description\" content=\"In my recent articles on how outcomes are assessed in clinical studies I have covered the minimal clinically important difference (MCID), a measure of how large a change in the [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-24T13:32:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-31T10:45:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Jeffrey-Aronson.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"540\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BMJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/\"},\"author\":{\"name\":\"BMJ\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\"},\"headline\":\"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary\",\"datePublished\":\"2019-05-24T13:32:16+00:00\",\"dateModified\":\"2019-05-31T10:45:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/\"},\"wordCount\":882,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2017\\\/02\\\/Jeffrey-Aronson.jpg\",\"articleSection\":[\"Jeff Aronson's Words\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/\",\"name\":\"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2017\\\/02\\\/Jeffrey-Aronson.jpg\",\"datePublished\":\"2019-05-24T13:32:16+00:00\",\"dateModified\":\"2019-05-31T10:45:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2017\\\/02\\\/Jeffrey-Aronson.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2017\\\/02\\\/Jeffrey-Aronson.jpg\",\"width\":540,\"height\":350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/05\\\/24\\\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\",\"name\":\"BMJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"caption\":\"BMJ\"},\"sameAs\":[\"https:\\\/\\\/blogs.bmj.com\\\/\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/","og_locale":"en_US","og_type":"article","og_title":"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary - The BMJ","og_description":"In my recent articles on how outcomes are assessed in clinical studies I have covered the minimal clinically important difference (MCID), a measure of how large a change in the [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2019-05-24T13:32:16+00:00","article_modified_time":"2019-05-31T10:45:03+00:00","og_image":[{"width":540,"height":350,"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Jeffrey-Aronson.jpg","type":"image\/jpeg"}],"author":"BMJ","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"BMJ","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/"},"author":{"name":"BMJ","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe"},"headline":"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary","datePublished":"2019-05-24T13:32:16+00:00","dateModified":"2019-05-31T10:45:03+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/"},"wordCount":882,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Jeffrey-Aronson.jpg","articleSection":["Jeff Aronson's Words"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/","url":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/","name":"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Jeffrey-Aronson.jpg","datePublished":"2019-05-24T13:32:16+00:00","dateModified":"2019-05-31T10:45:03+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Jeffrey-Aronson.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Jeffrey-Aronson.jpg","width":540,"height":350},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/05\/24\/jeffrey-aronson-when-i-use-a-word-outcomes-primary-and-secondary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"Jeffrey Aronson: When I use a word . . . Outcomes, primary and secondary"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe","name":"BMJ","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","caption":"BMJ"},"sameAs":["https:\/\/blogs.bmj.com\/"],"url":"https:\/\/blogs.bmj.com\/bmj\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/44698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=44698"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/44698\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media\/38359"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=44698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=44698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=44698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}